Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies
- PMID: 24828779
- PMCID: PMC4459499
- DOI: 10.1111/jcpt.12171
Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies
Abstract
What is known and objective: Tobacco smoking remains a major health problem. Nicotine binds to nicotinic acetylcholine receptors (nAChRs), which can cause addiction and withdrawal symptoms upon cessation of nicotine administration. Pharmacotherapies for nicotine addiction target brain alterations that underlie withdrawal symptoms. This review will delineate the involvement of the β2 subunit of neuronal nAChRs in nicotine reward and in generating withdrawal symptoms to better understand the efficacy of smoking cessation pharmacotherapies.
Comment: Chronic nicotine desensitizes and upregulates β2 subunit-containing nAChRs, and the prolonged upregulation of receptors may underlie symptoms of withdrawal. Experimental research has demonstrated that the β2 subunit of neuronal nAChRs is necessary for generating nicotine reward and withdrawal symptoms.
What is new and conclusion: Smoking cessation pharmacotherapies act on β2 subunit-containing nAChRs to reduce nicotine reward and withdrawal symptom severity.
Keywords: nicotine reward; nicotine withdrawal; nicotinic acetylcholine receptor; smoking cessation; β2 subunit.
© 2014 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Brain β2*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler.Int J Neuropsychopharmacol. 2011 Apr;14(3):389-98. doi: 10.1017/S1461145710001227. Epub 2010 Oct 29. Int J Neuropsychopharmacol. 2011. PMID: 21029513 Free PMC article. Clinical Trial.
-
Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.Eur J Pharmacol. 2015 Apr 15;753:146-50. doi: 10.1016/j.ejphar.2014.05.062. Epub 2014 Aug 5. Eur J Pharmacol. 2015. PMID: 25107281 Free PMC article.
-
New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.Neuropharmacology. 2018 Aug;138:72-79. doi: 10.1016/j.neuropharm.2018.05.025. Epub 2018 May 21. Neuropharmacology. 2018. PMID: 29860196 Free PMC article.
-
Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype.Nicotine Tob Res. 2012 Nov;14(11):1258-69. doi: 10.1093/ntr/nts089. Epub 2012 Apr 6. Nicotine Tob Res. 2012. PMID: 22492084 Free PMC article. Review.
-
Reward, addiction, withdrawal to nicotine.Annu Rev Neurosci. 2011;34:105-30. doi: 10.1146/annurev-neuro-061010-113734. Annu Rev Neurosci. 2011. PMID: 21438686 Free PMC article. Review.
Cited by
-
α2-Null mutant mice have altered levels of neuronal activity in restricted midbrain and limbic brain regions during nicotine withdrawal as demonstrated by cfos expression.Biochem Pharmacol. 2015 Oct 15;97(4):558-565. doi: 10.1016/j.bcp.2015.06.015. Epub 2015 Jun 22. Biochem Pharmacol. 2015. PMID: 26111579 Free PMC article.
-
Effects of ceftriaxone on conditioned nicotine reward in rats.Behav Pharmacol. 2017 Sep;28(6):485-488. doi: 10.1097/FBP.0000000000000314. Behav Pharmacol. 2017. PMID: 28704277 Free PMC article.
-
Wheel running during chronic nicotine exposure is protective against mecamylamine-precipitated withdrawal and up-regulates hippocampal α7 nACh receptors in mice.Br J Pharmacol. 2018 Jun;175(11):1928-1943. doi: 10.1111/bph.14068. Epub 2017 Dec 22. Br J Pharmacol. 2018. PMID: 29266170 Free PMC article.
-
Increased Risky Choice and Reduced CHRNB2 Expression in Adult Male Rats Exposed to Nicotine Vapor.Int J Mol Sci. 2022 Jan 22;23(3):1231. doi: 10.3390/ijms23031231. Int J Mol Sci. 2022. PMID: 35163155 Free PMC article.
-
Nicotinic receptor blockade decreases fos immunoreactivity within orexin/hypocretin-expressing neurons of nicotine-exposed rats.Behav Brain Res. 2016 Nov 1;314:226-33. doi: 10.1016/j.bbr.2016.07.053. Epub 2016 Aug 1. Behav Brain Res. 2016. PMID: 27491589 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. Current Cigarette Smoking Among Adults – United States. 2011:2012a. - PubMed
-
- Centers for Disease Control and Prevention. Surgeon General’s Report – The Health Consequences of Smoking. 2004 - PubMed
-
- Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses – United States, 2000–2004. 2008 - PubMed
-
- Nides M. Update on pharmacologic options for smoking cessation treatment. Am J Sci. 2008;121:S20–S31. - PubMed
-
- Benowitz NL. Nicotine addiction. Tob Use Cessat. 1999;26:611–631. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical